Aberrant expression of TSG101 in Taiwan Chinese breast cancer

Citation
Yf. Lo et al., Aberrant expression of TSG101 in Taiwan Chinese breast cancer, BREAST CANC, 60(3), 2000, pp. 259-266
Citations number
21
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BREAST CANCER RESEARCH AND TREATMENT
ISSN journal
01676806 → ACNP
Volume
60
Issue
3
Year of publication
2000
Pages
259 - 266
Database
ISI
SICI code
0167-6806(200004)60:3<259:AEOTIT>2.0.ZU;2-7
Abstract
Functional inactivation of the tsg101 gene in mouse fibroblasts results in cell transformation and the ability to form metastatic tumors in nude mice. The human tsg101 gene was mapped to chromosome 11q15.1-2 and found to muta te in some cancer patients. To test the expression pattern of the tsg101 ge ne in Chinese breast cancer patients, we analyzed the mRNA by RT-PCR in 51 breast cancer patients. The full-length tsg101 and 7 truncated transcripts were detected in both normal and matched tumor tissues. A short transcript with a deletion of nucleotides 154-1054 is frequently presented in late-sta ge breast cancers. TSG101 protein expression was also detected by Western b lot analysis in 30 breast cancer patients. A predicted full-length 46 kDa a nd three proteins with smaller molecular weight were detected. The full-len gth 46 kDa protein was less expressed in tumor specimens. Immunohistochemic al stains from 10 patients of each stage 0-4 revealed that TSG101 protein w as predominantly present in the cytoplasm. Cell nuclei were occasionally im munopositive and the chromosomes were deeply stained during cell division. The intracellular location and the expression of TSG101 protein were both n ot stage-dependent in primary breast cancers. In addition, normal mammary g lands were more homogenously immunopositive than invasive ductal carcinoma. These results support the notion that the aberrant expression of TSG101 in breast cancer is associated with altered cell growth.